Every post your clinic publishes passes one desk

Dubai received 691,000 medical tourists in 2023, who spent AED 1.03 billion on treatment directly and a further AED 2.3 billion on everything else a visitor buys. Dermatology accounted for twenty-seven per cent of that demand, second only to dentistry, and fifty-eight per cent of the patients were women. They arrived from Asia, which supplied a third of them, from the GCC, which supplied twenty-eight per cent, and from Europe and the CIS, which supplied roughly a quarter.

An aesthetic clinic reading those numbers reaches an obvious conclusion. The audience is large, international, predominantly female, and reachable on exactly the channels the category already lives on. The answer must therefore be more content, in more languages, more often.

That conclusion is reasonable, widely held, and in this particular market it is the wrong diagnosis.

What the rules actually require

Health advertising in Dubai is governed by the Dubai Health Authority, and the requirements are considerably more specific than most clinic owners realise until they are audited. The material provisions, for a marketing team, are these.

• -Every post that names or references the facility requires the medical director's approval. Not the marketing manager's, and not an agency's. The medical director is also required to train the staff involved, to designate who may moderate the accounts, and to archive published material for inspection.
• -Written consent is mandatory before any patient's photograph, video or statement appears in an advertisement.
• -Before-and-after images carry technical conditions. They must show the same person, be taken with identical lenses, remain unedited, and carry a disclaimer that results vary between individuals.
• -A substantial vocabulary is prohibited. Superlatives and absolutes including best, safest, miraculous, unique, exclusive, one hundred per cent, no side effects and immediate results are not permitted, nor is any negative comparison with another practitioner or facility.
• -Titles must match the licence. Descriptions such as Cosmetic Specialist, Aesthetic Consultant and Anti-Ageing Specialist are not permitted, and the use of Dr is restricted to physicians, dentists and recognised doctoral holders whose certificates have been attested.
• -Influencer content is the facility's responsibility. An influencer promoting the clinic requires the medical director's approval, and the medical director remains liable for what is filmed on the premises.

Read that list again with an operational eye rather than a legal one. Almost every clause routes back to a single individual, who is a practising clinician with a patient list, and who carries personal professional liability for material they did not write.

Why producing more makes it worse

A marketing function that doubles its output, in a system where every item must pass one desk before publication, has not doubled its marketing. It has doubled the queue in front of a clinician. What follows is predictable and observable across the sector: approvals are given in batches at the end of a clinic day with less attention than they deserve, or they are not given at all and the calendar slips, or the practice quietly drifts towards publishing the safe material that needs no real review, which is the material least likely to generate an enquiry.

This is the point at which the usual advice about artificial intelligence in marketing becomes actively unhelpful. The promise of generating five times the content is not a benefit here. It is a threat to the only part of the process with no slack in it.

What is actually worth rebuilding

If the constraint is approval rather than production, then the work worth doing is the work that arrives at that desk. Three things change the position materially.

The first is pre-flight compliance. Every item routed to the medical director can be checked first against the things that are mechanically checkable: prohibited vocabulary, title usage, the presence of the variability disclaimer on before-and-after material, whether a consent record exists and is attached, and whether the claim being made is one the clinic is licensed to make. None of that requires clinical judgement. All of it currently consumes clinical attention, because the medical director is the first person to see the draft.

The second is the consent and archive record itself, which the regulations require and which most clinics maintain as a folder of screenshots. It is an audit obligation that will be tested eventually, and it is entirely mechanical.

The third is the enquiry, which in this category arrives on Instagram and WhatsApp, at any hour, in several languages, from three source regions in different time zones, and which is answered by whoever is on the front desk. The product being sold at that moment is not the procedure. It is the consultation, and the conversion from enquiry to booked consultation is where the commercial outcome of all the marketing is actually decided.

The counter-argument, fairly put

There is a serious objection, and clinic owners should hear it stated plainly rather than discovered later.

An automated compliance check creates a risk of false assurance. The medical director's liability is personal and is not transferred by any system, and a practice where drafts arrive marked as checked may review them less carefully than one where they arrive raw. That would be a worse outcome than the queue, and it is a real possibility rather than a theoretical one. The mitigation is that pre-flight checking should be presented as filtering, never as approval, and the record should show what was checked mechanically and what still requires a clinician's judgement. If a clinic cannot hold that distinction, it should not build the system.

The second objection is narrower but worth stating. Aesthetic medicine sells reassurance and taste alongside outcomes, and the voice a clinic uses is part of what a patient is buying. Material assembled to a formula reads as assembled, and in a category where the patient is deciding whether to trust somebody with their face, that is not a small cost.

What I would do

• 01Measure the queue before anything else. Take one month and record the interval between a draft being ready and being approved, and how many items were published late or abandoned. Most clinics have never looked at this number and are surprised by it.
• 02Build the pre-flight check before building any content capability, so that increased volume arrives at the medical director already filtered rather than merely larger.
• 03Treat the enquiry-to-consultation conversion as a separate project from marketing altogether. It is where the money is decided, it is currently handled by the least senior person in the building, and it is the one part of this that carries no regulatory constraint at all.